http://www.aktiencheck.de aktiencheck.de aktiencheck.de Tue, 21 Apr 2026 22:50:53 +0200 2 http://www.aktiencheck.de/forum/Vaxgen_923976_ueber_100_Kursanstieg_seit_EILT_DRINGEND-464800-t36167 http://www.aktiencheck.de/forum/Vaxgen_923976_ueber_100_Kursanstieg_seit_EILT_DRINGEND-464800-t36167 Gegen Anthrax wid auf Vaxgen gesetzt, 17 Dollar., Gruss E. VaxGen Submits Proposal to Produce Up to 75 Million Doses of Anthrax Vaccine; Discontinues Plague Vaccine Program BRISBANE, Calif., Apr 28, 2004 (PRNewswire-FirstCall via COMTEX) -- VaxGen announced today that it has submitted a proposal to the U.S. Department of Health and Human Services (HHS) describing its plan to provide up to 75 million doses of its recombinant anthrax vaccine to the U.S. strategic national stockpile of biodefense products. The HHS has indicated that it intends to award purchase contracts for such a vaccine on or about August 9, 2004. (Photo: http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO ) VaxGen has already received two contracts from the National Institute of Allergy and Infectious Diseases (NIAID) to develop its recombinant anthrax vaccine candidate. The contracts are valued at more than $100 million. The company is also developing an attenuated smallpox vaccine in part [<a href="http://www.aktiencheck.de/forum/Vaxgen_923976_ueber_100_Kursanstieg_seit_EILT_DRINGEND-464800-t36167">mehr</a>]